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ABSTRACT
Benthic dinoflagellates of the genus Ostreopsis are important components of subtropical and 
tropical marine coral reef-lagoonal environments. Currently, as a result of  global warming and 
trade globalization, they are also distributed worldwide. These microalgae are shown to produce
palytoxin, one of the most potent non-protein marine toxins known.
The hemolytic assay is a very easy, rapid and sensitive method to determine palytoxin. However, 
under the conditions reported in previous works this assay is inadequate for a rigorous dose-
response treatment, since: 1) it produces degenerate sigmoidal profiles, with a pronounced slope 
which makes the calculation of the ED50 very sensitive to the experimental error; 2) at the usual 
work temperature, the in vitro stability of the system is low, which accentuates the variability 
and ambiguity of the response. To resolve these problems hemolysis of sheep erythrocytes by 
palytoxin is studied including its toxicological dynamics, its kinetics, its inhibition by ouabain 
and its response to temperature. The results show that, to obtain a smoother, more stable and 
reproducible response, it is necessary to apply two resources simultaneously: operation at a 
moderate temperature and partial inhibition of the palytoxin by ouabain. It also produces highly 
reliable parameters and allows strict equivalencies to be established with the mouse bioassays, a 
traditional reference point, though bioethically questionable and 20 times less sensitive than the 
bioassay proposed here.
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1. INTRODUCTION
Palytoxin is a polyol compound that shows extreme acute toxicity (Moore & Scheuer 1971). This 
toxin has been primarily isolated from marine Coelenterates of genus Palythoa and shows 
remarkable biological activity at an extremely low concentration. The intoxication produced by 
palytoxin represents a serious threat, as there have been a number of deaths  associated with the 
ingestion of contaminated seafood. Deaths have reportedly occurred after comsumption of 
contaminated crabs in the Philipines (Alcala et al. 1988), sea urchins in Brazil (Granéli et al. 
2002) and fish in Japan (Fukui et al. 1987; Onuma et al. 1999; Taniyama et al. 2003) etc…
As other neurotoxins, palytoxin can be quantified via traditional mouse bioassays, which were 
first carried out over 50 years ago (Thompson 1947, Thompson & Weil 1952, Weil 1952) and 
have basically remained unchanged ever since. These assays quantify the mortality of a small 
population of animals, which follows a violent and unusual contraction of its striated and smooth 
musculature, with increasing doses of the effector. As well as its neurotoxic character, another 
characteristic property of palytoxin is its capacity to bind, in mammal erythrocytes, to the 
external part of the Na+/K+ pump converting it into an ionic channel, which causes the rapid 
depletion of K+, followed by delayed coloidosmotic hemolysis (Habermann et al. 1981, Artigas 
& Gadsby 2003, Hilgemann 2003). The hemolysis by palytoxin is specifically inhibited by 
Ouabain (Habermann & Chhatwal 1982), a glycoside that binds to the sodium pump in the same 
place as palytoxin does.
Mouse bioassays are criticised for bioethical and economic reasons, which have led to the 
development of other methods to minimise the death of animals, but which are less accurate. As 
in the case of the traditional method of moving averages (Thompson 1947, Thompson & Weil 
1952, Weil 1952) or the more recent anaesthetic one (Holtrop et al. 2006). Abandoning these 
bioassays, however, is viewed reluctantly. Against chromatographic methods has been adduced 
their inability to assess the real biological activity when the toxin is accompanied by active 
structural analogues. Against methods based on delayed hemolysis –free from this previous 
problem and able to support a satisfactory bioassay– the objection is the lack of identification 
value of the symptoms prior to the mouse’s death. However, the methods based on the hemolytic 
effect are dependent on the same molecular or toxoforic architecture as the neural fault of the 
mouse. 
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The use of empirical models is common in the evaluation of the activity of marine toxins. 
Regrettably, such models do not take into account the basic facts of the general relationships 
between the effector doses and the response produced in the target population (DR 
relationships). They usually search for simple linear forms throughout transformations 
(logarithmic and reciprocal). This reduce their accuracy, introduce biases and therefore cannot be 
justified nowadays adducing the complexity of the work with non-linear models. Furthermore, 
the parameters of these models lack of biological significance, which give rise to uncertainties in 
their use and can not be extrapolated to other systems. The advantage of the mechanistic and 
semimechanistic models is the establishment of a much stronger relationship of equivalence.
In this research, the toxicological dynamics of hemolysis by palytoxin and its inhibition by 
ouabain is studied using models whose foundations have been discussed in detail in previous 
studies, and whose form has been refined to adapt them rigorously to the description of DR 
relationships (Murado et al. 2002, Murado & Vázquez 2007). The thermal stability of the system 
is also investigated through the Arrhenius approximation, demonstrating that the formal methods 
applied produce coherent kinetic and dynamic descriptions. Information obtained in this way is 
used to define a sensitive and reliable assay which, under moderate temperature and partial 
inhibition of the palytoxin by ouabain, allows to obtain responses which give consistent and 
precise parametric estimations.
2. MATERIALS AND METHODS
2.1. Experimental methods
PBS solution: The vehicle for erythrocyte, palytoxin and ouabain dilutions was a solution 
containing 0.1 % bovine serum albumin (BSA), 1 mM calcium chloride (CaCl2·2H2O) and 1 mM  
boric acid (H3BO3) in phosphate buffered saline (PBS) 0.01 M, pH 7.4 (Sigma)
Palytoxin solution: The solution of palytoxin used, obtained from Palythoa tuberculosa, was 
provided by Wako Chemicals (Wako Chemical Industries, Ltd., Japan) as 100 µg of dry extract 
that was suspended in MeOH : Water (1:1) at 25 ng·µL-1 final concentration. Assays were 
performed by using the following series of dilutions in PBS: 2.500; 1.250; 1.000; 0.750; 0.660; 
0.580; 0.500; 0.375; 0.250; 0.125; 0.050 and 0.025 (pg·µL-1)
Ouabain solution: Starting from1 mM solution, the following dilutions in PBS were prepared: 1, 
2, 3, 4 and 5 µM. To carry out the experiment with ouabain the 1:99 erythrocytes dilution was 
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prepared with 50% of each one of the ouabain concentrations cited above and incubated to the 
specific temperature for 30 minutes before the assay.
Erythrocyte preparation: Sheep blood in Alsever was kindly provided by I. Manzano (CZ 
Veterinaria, S.A.; Porriño, Spain). Erythrocytes were separated from plasma by centrifugation 
(400 g, 10 ºC, 10 minutes), washed twice with PBS solution, then a first dilution (1:9) of 
erythrocytes in PBS at final concentration around 1.7 x 108 red cells·mL-1 was prepared. 
Assay procedure: The Hemolytic assay is based on Bignami´s method (Bignami 1993). Two 
blood solutions with and without ouabain were prepared to the same final concentration of 
approx 1.7107 erythrocytes·mL-1as follows:
i) Blood solution without ouabain: 1 volume of the erythrocyte preparation was 
combined with 9 volumes of PBS solution. 
ii) Blood solution with ouabain: 1 volume of the erythrocyte preparation was combined 
with 4 volumes of PBS solution and 5 volumes of the appropriate ouabain dilution 
and the mixture were incubated to the desired temperature during 30 minutes.
Next, 1 volume of each one of the previously blood solutions mentioned was mixed with 1 
volume of the appropiate palytoxin dilution and incubated over pre-established times at the same 
temperature.
The control solutions were prepared as follows:
i) hemolysis 0% (Blank): was prepared by mixing both blood and PBS solutions (1:1) 
ii) hemolysis 100%: was achieved by mixing blood solution and distilled water (1:1).
After the incubation period, erythrocyt s were separated by centrifugation (300 x g, 10ºC, 10 
min). A 200 µL portion of each supernatant was further transferred to a microwell plate to 
measure the absorbance at 405 nm into a microplate reader. 
It must be taking into account that concentrations of erythrocytes, ouabain and palytoxin in the 
final reaction mixture are respectively equal to ½, ¼ and ½, of their values in the original 
preparations, but references will only made to the original concentrations to avoid confusions. 
To study the effect of temperature on the reaction rate by means of the Arrhenius’ model, the 
hemolytic activity induced by a 0.25 pg.µl-1 palytoxin solution at 15, 20, 25, 35, 40 and 45 ºC 
was checked over a period of 15 hours. Analyses were performed in centrifuge tubes with 
enough volume to transfer triplicate aliquots of 300 µl to a 96-well microtitre plate at intervals of 
30 minutes or 1 hour depending on the reaction rate. Plate containing triplicate samples was 
centrifuged at 300 g and 10ºC for 10 minutes (Sigma K10 centrifuge equipped with a Sigma 
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11222 microplate rotor). After centrifugation a 200 µL portion of each supernatant was 
transferred to another plate to measure absorbance at 405 nm into a microplate reader (BioRad 
550).
2.2 Numerical methods
Fitting procedures and parametric estimations from the experimental results were performed by 
minimisation of the sum of quadratic differences between observed and model-predicted values, 
using the non-linear least-squares (quasi-Newton) method provided by the macro ‘Solver’ of the 
Microsoft Excel XP spreadsheet. Subsequently, confidence intervals of the parametric 
estimations (Student’s t test) and consistence of mathematical models (Fisher’s F test) were 
determined using the non-linear section of Statistica 6.0 pack (StatSoft, Inc. 2001).
3. RESULTS AND DISCUSSION
3.1. Dose equivalence in assays of the same effector on two different receptors
To evaluate the effect of palytoxin on mice in vivo using its hemolytic effect on in vitro sheep 
erythrocytes, a relationship between the functions that describe corresponding responses needs to 
be established: to define in assay 1 a dose D1 that produces the same response RI  as the dose D2
in assay 2. Generally speaking, the descriptive functions can be expressed, in terms of dose D
and three parameters, as:
R = f (D; K, m, ) [1]
K being the maximum response, m the dose that corresponds to the semi-maximum response and 
 being a parameter related to the response slope, in a way which varies according to the specific 
function under consideration. In this way, we can write:
   1 1 1 1 1 2 2 2 2 2; , , ; , ,iR f D K m f D K m   [2]
Usually the two responses can be described by the same model; in other words, f1 and f2 will 
have the same functional form, although this is not an essential condition. In any case, once the 
parametric values of both models have been estimated, to obtain one of the doses as a function of 
the other, we can formulate a conversion function () of the type:
 1 2 1 1 1 2 2 2; , , , , ,D D K m K m   [3]
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In this study, and for reasons discussed previously (Murado et al. 2002, Murado & Vázquez 
2007), the descriptive functions used were the logistic equation and the cumulative function of 
the Weibull distribution, both modified to adapt them to DR analysis (See appendix A).
The modified logistic equation (hereinafter mL) has the form:
 
1 1
1 exp
KA
R
B B D A
     
[4]
where:   exp 1A m   ;  exp 2B m    ;   and:
R response, with K as maximum value.
m dose corresponding to semi-maximum response.
 maximum specific rate (increment of R by unit of R and unit of D).
and when the DR relationships involved in the transformation are described via this model, the 
conversion function   which allows the determination of dose D1 that produces in assay 1 the 
same response Ri as the dose D2 in assay 2 is:
1
1
1
1
ln
P
B P
D 
   
    ;  where: [5]
2 1 2
1 2 1 1
1A B K
P Q
A B K A
      ;    
2 2 2
1 1
1
Q
B E A
 
    ;     2 2 2expE D 
On the other hand, the modified Weibull function (hereinafter mW) has the form:
1 exp ln 2
a
D
R K
m
              
[6]
R response, with K as maximum value.
m dose corresponding to semi-maximum response.
a form parameter, related to the maximum slope of the response.
the conversion function  being in this case:
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1 1
ln
ln 2
a
S
D m
    
 ;  where: [7]
 2 2
1
1
1
K E
S
K
       ;    
2
2
2
2
exp ln 2
a
D
E
m
        
Figure 1 illustrates the main precaution that should be taken into account when applying any of 
the  functions, a precaution that consists of avoiding the domains of the dose in which the 
reference response gets close to initial starting stage or to the asymptotic end. In other words: the 
conversion is more precise the closer the doses involved D1 and D2 are to the parametric values 
m1 and m2.
3.2. The hemolysis of palytoxin at 37ºC
The hemolysis kinetics at different levels of palytoxin at 37ºC produced the results seen in figure 
2A, whose sigmoidal profiles in time are due to, in principle, two different reasons: 1) the action 
of some autocatalytic mechanism, similar to that produced if the hemolysis were accelerated by 
some of its products; 2) the populational nature of the DR phenomenon, since if the determining 
factors of sensitivity are random variables subject to some probability distribution, the response, 
i.e. the corresponding cumulative function will have to be sigmoidal with respect to dose and 
time (the entities that are more sensitive than average will respond to lower doses and a shorter 
time, and the opposite will occur for those that are less sensitive). Therefore, to explain the 
kinetic profile of the hemolysis, it is sufficient to accept that the number of palytoxin receptors 
by erythrocyte; the number of receptors that should be occupied by the toxin so that hemolysis 
takes place; or the affinity between receptor and toxin are not constant in all the erythrocytes, but 
variables with some probability distribution within the assay erythrocyte population.
Although later on we deal experimentally with this dilemma, here we should point out that in the 
second case the models mL and mW are adequate to describe the kinetics of the hemolysis, using 
time, instead of dose, as the independent variable. Taking into account that mammal erythrocytes 
are dead cells, the said kinetics can be assimilated to a time of failure of any complex system, 
conventionally described by the Weibull distribution (Canavos 1992, Shalel et al. 2002). 
Therefore, the model applied to the process was mW:
0.5
1 exp ln 2
a
t
R K
t
              
[8]
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R response as proportion of hemolysis with K as maximum value.
t0.5 time corresponding to semi-maximum response.
a form parameter, related to maximum rate of hemolysis.
In all cases the model was consistent (Fisher’s F, =0.05) and led to significant estimates 
(Student’s t, =0.05) of all the parameters (figure 2B), with a high correlation between observed 
and expected results (r=0.999; figure 2C).
Naturally, every perpendicular to the time axis in figure 2B produces, at their intersections with 
the kinetic profiles, a series of values that represent, at a given time of exposure, the response to 
the dose series used, once again with a sigmoidal profile that fits the models mL or mW. If the 
responses at a given time are normalised, and are expressed as a fraction of the maximum of that 
time, then ideally any exposure time will lead to the same set of parameters, although in reality 
there can be deviations due to the different relative weight of experimental error at different 
times and at different doses. 
Considering the series at 250, 300 and 350 minutes together, the fit to the models mL or mW 
(figure 2D and note b of Table 1) was consistent and the parameters statistically significant. 
However, the correlation between observations and predictions (despite an acceptable value: 
r=0.967; figure 2F) clearly showed groupings that reveal the lack of strict equivalence between 
the three series, a result connected with the fact that the value of parameter t0.5 was not totally 
independent of the doses (figure 2E), dropping asymptotically from the lowest doses.
This situation makes it necessary to define some decision criteria to select the most appropriate 
incubation time. A problem which requires the following solutions:
S1. Use a time in which all kinetics have reached the asymptote (all the hemolyses have 
reached the equilibrium). At least for this present case, this criteria leads to the lowest 
value of m, which represents a factor of safety.
S2. Obtain a unified description of the response as a simultaneous function of time and dose,  
without rejecting any of the times studied. In this case, the set of experimental results may 
fit a model that is the product of the equations mL and mW, divided by the common 
asymptote (K) of the two dimensions of the response. One option is to use mW with time 
and mL with the dose (mWtmLD):
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 0.5
1 1
1 exp ln 2  
1 exp
a
t A
R K
t B B D A
                             
[9]
but any one of the four products mWtmLD, mLtmVD, mWtmWD y mLtmLD is in principle a 
feasible model.
Although unusual in DR analysis, this bidimensional model comprises the most complete 
description for the overall average of experimental data. Applied to the present case (figure 3A, 
Table 1), both the equation [9] and its alternative mWtmWD were consistent and produced 
statistically significant parametric estimates. However, once again, the correlation between 
observations and predictions showed, within its linearity (r=0.996; figure 3B), groupings which 
reveal bias in the predictions (in which the value of m does not depend on time, when, in reality, 
the longer times tend to produce higher estimations of m). In fact, although the criteria applied in 
figures 2D and 3 generate undistinguishable estimates of m (25.3  3.9 y 29.2  7.0 pg.ml–1), if 
the responses in the asymptotic stage of the kinetics are used, the value drops to 14.5  3.0 
pg.ml–1.
This effect could be due to a spontaneous hemolysis over time, which exceeds that in the control 
without palytoxin, and which is not directly due to the concentration of the toxin, but to some 
liberating  factor by damaged erythrocytes, i.e., to a low intensity catalytic effect (we will come 
back to this problem later on). Furthermore, the high sensitivity of the erythrocytes to palytoxin, 
under assay conditions, generate DR curves with a degenerated sigmoidal profile, whose marked 
slope makes the calculation of parameter m unusually sensitive to experimental error. In the next 
section we shall see how the temperature of the assay can be an important source of variability.
Given the fact this study attempts to establish reference points to evaluate toxin activity, it could 
opt for the most prudent solution of the lowest m. This, however, would not eliminate the 
problems connected with the assay conditions that we have just mentioned. Therefore a better 
solution seemed to be to reduce the intensity of the response through two methods: operation at 
low temperatures and the addition of ouabain, which occupies the same receptors in the 
erythrocyte membrane as palytoxin, thus acting as a competitive inhibitor.
3.3. Influence of temperature and fit of hemolysis to the Arrhenius model.
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To determine the temperature effect on the rate of hemolysis, a kinetic assay was carried out in 
which the same concentrations of erythrocytes and palytoxin were incubated at 7 temperatures 
between an interval of 15 and 45ºC. The results (figure 4), in terms of percentage of hemolysis 
fit a classic logistic equation:
 1 exp
m
m
H
H
c t     ;  being 0
ln 1m
H
c
H
   
 
[10]
H percentage of hemolysis, with H0 and Hm as initial and maximum values.
m maximum specific rate (increase in H by unit of H and unit of t).
The meaning of the maximum specific rate (m) can assimilate to that of an initial reaction  rate, 
but in sigmoidal kinetics the criterion of maximum rate (vm) can be more robust, in the sense of 
being less sensitive to experimental error. With the aim of comparing the descriptive aptitude of 
both parameters, a reparametrized version of [10], to make the maximum rate explicit (Vázquez 
et al. 2006), was also used: 
 41 exp 2
m
m
m
H
H
v
t
H


     
[11]
vm maximum rate (increase of H by unit of t).
 delay (intersection of the tangent at inflection point with the x axis).
In both cases (Table 2) the equations were consistent and the parametric estimates statistically 
significant.
Now then, according to the Arrhenius definition, the relationship between the rate of a chemical 
reaction and the temperature of a system is described by the equation: 
   exp a rr E kk T A R T
     
  ;   or, in linear version: [12]
 
ln ln a rr
E k
k A
R T
   [13]
with kr being  the kinetic constant, Ea  the activation energy, R the constant of gases and T the 
absolute temperature (the meaning of the pre-exponential term A is limited here to only a fitting 
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parameter). Given that the substitution in [13] of the kinetic constant kr for either of the rate 
parameters (m or vm) is dimensionally coherent, we can write:
 
1ln ln
a m
m
E
A
R T
    [14]
 
2ln ln
a m
m
E v
v A
R T
  
[15]
The representations of both functions (figure 5) clearly showed that the rate increases with the 
temperature from 15 to 35ºC, and rapidly falls after the latter value, suggesting the 
disorganisation of the biological system under these conditions. Furthermore, the fittings of the 
ascending tracts (of activation) to the models [14] and [15] were consistent, significant and 
demonstrated that the maximum rate (vm) provides a more robust criterion than the specific 
maximum rate (m).
The values obtained for activation energies (Ea; =0.05) were 18.89 6.42 and 12.72 2.16 
kJ/mol, using m and vm respectively. Although slightly lower, they are within the range of those 
other authors have determined in human erythrocytes for other hemolytic agents, such as the 
Kanagawa hemolysin and hypochloric acid (Huntley & Hall 1994, Zavodnik et al. 2002). The 
difference can be due to: 1) differences in the potential barriers of the corresponding effectors, a 
barrier that without doubt is very low in palytoxin, given its notable activity; 2) differences 
dependent on the species (Brzezinska-Slebodzinska 2003, Riobó et al. Unpublished) in the 
mechanical and structural resistance of the erythrocytes; 3) the common use of initial rates or 
first order kinetic models, which involve, as we have just demonstrated, less statistically robust 
parameters, and even distortion of the reality of the process, which requires the use of asymptotic 
equations such as those applied here.
Finally, it should be mentioned that 35ºC was a temperature that was very close to the domain at 
which thermal destabilisation of the biological system starts. This, without doubt, results in a 
high sensitivity to small variations in experimental conditions in this environment. This fact 
could contribute to the difficulties found in the fit of the results obtained at 37ºC, and, in any 
case, suggests the need to operate at lower temperatures.
3.4. Autocatalytic process versus populational response. Influence of ouabain.
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In section 2 we had pointed out the possibility of interpreting the sigmoidal character in time of 
the hemolysis as a result of an autocatalytic mechanism, in which the hypothetical release of 
some product from the cellular lysis acted as an activating cofactor of the process. In this case 
(See appendix B) the corresponding kinetics would follow the model:
 1
0
1 1 exp
m
m
H
H
H
k t
H

    
 
[16]
H0 and Hm  being the initial and final values of the hemolysis, and k1 the rate constant. This 
equation differs from mL [4], which describes the populational response, in its non null intercept, 
H0. However, as the value of H0 is necessarily low, comparing the fit of the kinetic data to [4] 
and [16] is a very unsafe criterion even with low experimental error, which makes the alternative 
between the autocatalytic process and populational response indescribable.
However, in the presence of a competitive inhibitor of hemolysis, such as ouabain, autocatalytic 
kinetics would follow the model (I being the concentration of ouabain): 
 
1 2
1
1 2
1 2
0 1
1 1 exp
m
m
k k I
H
k
H
H k k I
k k I t
H k
 
 
 
         
[17]
whereas in a populational response the ouabain effect could be described (Murado et al. 2002)
introducing in any type [1] sigmoidal model a factor with the form:
1i iF b I    ;  (i=K, m, ) [18]
which would multiply or divide K, m o , according to its effect raise or reduce the value of the 
corresponding parameter, leading to specific alterations in the response profile. 
Given that under these conditions the models differ more substantially, the presence of an 
inhibitor like ouabain enables us to decide between the autocatalytic and populational 
hypotheses. In this respect, the results obtained working with 0.25 ng.ml–1 of palytoxin in the 
presence of 2, 3, 4 and 5 µM of ouabain clearly supports the populational option. Indeed (figure 
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6), whereas the autocatalytic model with inhibition [17] resulted in very inadequate fits, both the 
equations mL [4] and mW [6] led to satisfactory simultaneous solutions of the set of kinetic 
profiles, once the factors Fi [18] had been introduced.
In the case of the equation mL, the factors FK and F divided the K and  values, whereas the 
factor Fm multiplied the value of m. In the equation 
mW, however, a divisor FK and a multiplier 
Fm were sufficient, Fa being null. It is interesting to note this characteristic, as it is the essential 
difference between the equations with regard to DR models: in mL the geometric elements of the 
curve vary independently with each parameter in mW, if m varies, the slope varies, too.
As far as we are interested here, these results showed that the inhibitory action of ouabain can be 
incorporated into the models that describe palytoxin activity without difficulty. Furthermore, the 
apparent parameters generated by the joint response do not alter (if the concentration of ouabain 
is known) the attribution of a specific dose of palytoxin to a specific hemolytic response. 
However, it is not so clear that the same results allow us to reject the hypothesis of a low 
intensity autocatalytic effect, as mentioned in section 2 with respect to a possible spontaneous 
hemolysis. 
3.5. Evaluation at 25ºC in the presence of ouabain.
Given the effects of temperature and ouabain on the response under study, the simultaneous 
action of both factors are considered an adequate resource to reduce the apparent potency of the 
toxin. Consequently, three new kinetics were carried out at 25ºC, in the absence and presence of 
ouabain 1 and 5 M, also redefining the series of palytoxin doses in order to obtain a greater 
number of values in the low concentration domain. The results, evaluated via the S1 and S2 
crtieria (figures 7 and 8; Table 1), showed the following facts:
1: Both criteria provide consistent descriptions and statistically significant parametric estimates. 
In the more intense responses, however, also at 25ºC the estimated potency was higher (the value 
of m lower) when the results at asymptotic times were used than when all the information in 
bidimensional model was used. 
2: The combined effect of the decrease in temperature and the presence of ouabain contributed 
not only to soften the response, but also to create the sigmoidal profile characteristic of DR 
relationships, to improve the correlation between observations and predictions in the 
bidimensional model and to make progressively convergent the estimates according to the 
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criteria S1 and S2. In fact, with ouabain 5 M the confidence intervals (=0.05) of the estimates 
of m for both criteria overlapped, making both values statistically indistinguishable.
3: Comparing the results at 25 and 37ºC in the absence of ouabain it is clearly seen that if higher 
temperatures slightly accelerate the response, the same does not happen to the potency: the m
values obtained through the criteria S1 and S2 at the two temperatures were statistically 
indistinguishable, even with a lower average (greater potency) at 25ºC according to S1. This 
situation was confirmed in two independent and complete series of experiments, with different 
erythrocyte preparations. Though unable to make a detailed interpretation of this fact, the results 
from the Arrhenius approximation suggest that the erythrocyte system is, under in vitro assay 
conditions, at 37º rather unstable, which could partially disorganise the palytoxin response 
mechanism. 
In a DR assay where the safety margin of the effector is very low (i.e., the slope of the function 
is very high), the calculation of the parameter m (i.e., the DL50) is relatively sensitive to 
experimental error, especially if the potency of the effector is very high (the m parameter is very 
low). This is precisely what happens in the case of palytoxin, therefore to obtain reliable 
parametric estimates it is necessary to work under conditions that, without altering the mode of 
action, reduces the intensity of the response and transforms a degenerated sigmoidal profile 
(more similar to a von Bertalanffy equation than a logistic one) into the sigmoidal profile 
expected according to the foundations of the DR phenomenon. As such foundations also require, 
according to the facts demonstrated in the previous sections, that the response is sigmoidal as a 
function of the time and the dose, a good criterion to define reliable conditions is the 
convergence between the solutions derived from S1 and S2. In other words, reliable conditions 
are those in which the normalized response to the dose series assayed is independent of the time 
under consideration, at least in the interval between t0.5  and the asymptotic response time.
3.6. The method proposed
Taking into account the results described in the previous sections, the method proposed here to 
determine the equivalent activity of palytoxin in a given matrix can be summarised in the 
following terms:
3.6.1. Reagents ( in solution or PBS suspension)
A. Erythrocyte preparation: 1.7×108 cells·ml–1 (dilution 1/10 from original blood)
B. Ouabain (5 M)
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C. Palytoxin dilution series: 8 to 10 values in the interval 10-1.200 pg.ml–1 
D. Dilution series from the extract that must be evaluated.
3.6.2. Procedure 
Have a number of experimental units available (tubes or microplate dishes) sufficient for the 
triple assay of the dilution series included in C and D.
3.6.2.1. Combine 1 volume of A, 4 volumes of PBS and 5 volumes of B (getting a dilution 
1/100 of original blood, 1.7×107 cells·ml–1). Incubate 30 minutes at 25ºC. 
3.6.2.2. Combine 1 volume of solution in 3.6.2.1 with 1 volume of D. Incubate 18-24 
hours at 25ºC.
3.6.2.3. Eliminate the cell residues by centrifuge (400 or 300 g depending on if they are 
tubes or microplates, 10 minutes, 10ºC) and measure absorbance at 405 nm in the 
supernatant. 
3.6.3. Blank, total hemolysis and calibration curve
For the blank assay (0% hemolysis) the procedure described above is used substituting D for 
PBS in 3.6.2.2. To determine the total hemolysis (100% hemolysis value), the procedure 
described above is used substituting D for distilled water in 3.6.2.2. The calibration curve is 
performed substituting D dilution series for C dilution series in 3.6.2.2.
Under these conditions, the semi-maximum response time is 400 minutes, and the asymptotic 
stage of the kinetics is reached at 1,000 minutes, with 70% hemolysis. The parameters 
obtained when the calibration data obtained from the above conditions are fitted to the models 
mL and mW are given in Table 3. The corresponding functions with normalised responses (K=1) 
at 960 minutes are shown in figure 8. These results represent the corresponding reference curves 
of hemolysis by palytoxin in the presence of ouabain (PHO), and not just the concentration of 
palytoxin, which, as mentioned in the introduction can be misleading.
CONCLUSIONS
In the previous sections the reasons for the reliability and legitimacy of a method for evaluating 
the toxicity of palytoxin have been discussed, establishing working conditions that allow the 
application of statistically robust dose-response model, whose parameters possess unequivocal 
biological significance.
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Leaving aside the development required for its justification, this method is very simple. In fact, 
once the protocol described in section 6 has been applied to an extract obtained from a sample of 
known weight, it is enough to: 1) fit the responses of the extract’s dilution series to an mL or mW 
equation, to obtain the parameter mdil or the dilution that corresponds to the semi-maximum 
response; 2) Fit the PHO calibration curve to an mL or mW equation to obtain the parameter mH 
or palytoxin concentration that corresponds to the semi-maximum response. In this way, the 
dilution activity mdil will be equivalent to the concentration mH  of palytoxin.
Taking into account that the mouse bioassay is the traditional reference for neurotoxins of the 
kind studied here, it can be useful to establish the equivalence between both assays, which is 
possible if both are described by the same models applied here. With regard to this, Table 3 and 
figure 9 define, next to the PHO curve mentioned in the previous section, the results, in terms of 
mL and mW equations, of a previous mouse assay (Riobó et al. Unpublished) with the following 
specifications: mortality in 24 hours of NMRI males with weights of 19.5 to 22g; 124 
individuals; dose expressed as concentration of (ng·ml-1) the solution intraperitonally injected. 
This shows that taking into account the dose for semi-maximum response, the hemolysis assay is 
approximately 20 times more sensitive.
The parameters of the mouse models can be used as permanent references to avoid more animal 
deaths. The parameters of the PHO models can be used, together with the conversion functions 
[5] and [7], to calibrate the curves obtained for each batch of erythrocytes and therefore enable 
us to express the results, if required, in terms of toxicity to the mouse.
Actually, however, the best option would be to dispense with the mouse assay, using the toxicity 
to this animal to establish the maximum acceptable dose (MAD) in humans, expressed in terms 
of palytoxin equivalents, and determine such equivalents through the hemolysis assay in the 
terms described above.
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Appendix A. The dose-response models used.
1. Modified logistic equation (mL)
Logistic equation can be transferred from its habitual formulation (as a model for describing an 
autocatalytic kinetics, or a biological growth) to the context of the DR relationships, where it 
would have the form:
 1 exp
K
R
c D    ;  with  0
ln 1
K
c
R
   
 
 ,  where: [A1]
R response, with R0 and K as minimum and maximum values, respectively.
D dose.
 maximum specific rate of response (maximum increment of the R per unit of R and 
per unit of D).
Although [A1] is sometimes used directly as DR model, in this application it is important to 
introduce two modifications:
1. To eliminate the intercept (to make R0=0), so that the model obeys the condition of null 
response at null dose. Besides a basic fact of the DR relationships, the condition R0=0 is useful 
for the calculation of the remaining parameters by means of non lineal fitting methods. Indeed, 
with real data, affected of experimental error, the calculation can lead to unacceptably high 
values of R0. The problem decreases including restrictions that limit R0 to very low values, but it 
can create biases in the value of , very sensitive to the experimental error, in particular to 
overestimations –frequent in the practice– of the response at low doses.
2. To reparametrize the equation, so that it includes explicitly the dose for semi-maximum 
response (ED50, LD50, m in our notation), an essential parameter in the DR analysis. It allows the 
direct calculation of the corresponding confidence interval by means of computer applications as 
Statistica or MatLab.
Beginning with the reparametrization, if we make R=K/2 in [A1], we have c = m, and therefore:
 1 exp
K
R
m D    
[A2]
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Now, since the intercept (R for D=0) of [A2] is:
 0 1 exp
K
R
m 
the logistic equation without intercept is:
   
1 1
1 exp1 exp
R K
mm D 
 
       
[A3]
In this last equation, however, K and m do not represent the maximum response and the dose for 
semi-maximum response, respectively, the real values of which (Kr and mr) can be obtained from 
[A3]:
 
 
exp
lim
1 expr D
m
K R K
m


     
[A4]
 1 ln 2 exprm m    [A5]
So that the model includes such real values, K and m could be isolated from [A4] and [A5], and 
the resulting expressions to be introduced in [A3]. A simpler resource, however, is to reorder 
[A5] in the form:
   exp exp 2rm m  
and to substitute, in [A3] and [A4], the term exp(m) for its equivalent one, what leads to the 
form:
 
       
exp 1 1 1
exp 2 exp 11 exp exp 2
r r
r rr
K m
R
m mD m

  
              
[A6]
For simplifying the notation, it can be made:
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 exp 1rA m   ;  exp 2rB m   ;  and therefore:
 
1 1
1 exp
KA
R
B B D A
     
[A7]
which is the mL model used in this work.
2. Modified accumulative function of the Weibull’s distribution (mW)
In terms of DR model, the original accumulative Weibull’s function would be ( and  being 
parameters of form and scale, respectively):
1 exp
a
D
R 
         
[A8]
This form has the advantage on the logistic model of its null intercept. However, its use as a DR 
model makes convenient two modifications:
1. Multiplication of the second member for the maximum response K, so that the asymptote can 
take values different from 1:
1 exp
a
D
R K 
              
[A9]
2. Reparametrization of the equation, to make explicit the dose (m) for semi-maximum response. 
This way, if we make R=K/2 in [A9], we have:
 1/ln 2 am   ;  1/ln 2
m
 
what leads to the definitive form:
1 exp ln 2
a
D
R K
m
              
 ;  where: [A10]
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R response, with K as maximum value.
m dose for semi-maximum response.
a form parameter, related with the maximum slope of the response.
which is the mW model used in this work.
Appendix B. Description of an autocatalytic process with competitive inhibition.
To describe in a formal way the possible autocatalytic formation of the hemolysis products (H) 
due to palytoxin (P) in the presence of ouabain (I), we can admit an autocatalytic mechanism 
(that, for further generality, we will consider reversible, although this hypothesis is not pertinent 
in this case), simultaneous with a competitive irreversible inhibition:
rH1:
1
1
k
k
H P nH

 
rH2: 2
kH I HI 
Applying the mass action law, the process is defined by the following differential equations:
1
1 1 1
nm
H
m
H HdH
r k H k H
dt H 
       
 
2
2 2H
dH
r k H I
dt
   
1 2
1 2 1 1 2
nm
H H H
m
H HdH dH
r r r k H k H k H I
dt dt H 
             
 
[B1]
In the non trivial simplest (n=2) case, we have:
 2 2 11 1 2 1 2 1mH
m m
H H kdH
r k H k H k H I H k k I H k
dt H H 
                     
   
or, by making 1 2k k I      and  1 1
m
k
k
H
   [B2]
 2H dHr H H H Hdt            
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By separation of variables and subsequent integration:
 
0 0
H t
H
dH
dt
H H      [B3]
The integral in the first member can be solved by means of the decomposition:
 
1 A B
H H H H          ; that leads to:
  0
1
H A B
A


     
   
 por lo que: 
1
A   ; B


In this way, [B3] can be reformulated as:
 
0 0
1H H
H H
dH dH
t
H H

          ;  that is to say:
 
0 0
1 1
ln ln
H H
H H
H H t            ;    0 0
1 1
ln ln
H H
t
H H
 
   
              
Reordering and isolating H:
0
0 0
0 0
    
1 1 1
t
tt
t t
H e
H
eH H e
e e
H H


 
   
   
 

 
   
               
Finally, restoring to  and  their values according to  [B2], we obtain:
 1 2
1 2
1 1
1 2
0 1 1
1  1
m
m
k k I tm
m
k k I
H
k k H
H
H k k I
e
H k k H

  

  
   
           
[B4]
It should be observed that if the autocatalytic reaction rH1 is irreversible (k–l=0), we obtain the 
expression [17], used in the section 4 as a contrast against the populational hypothesis:
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 1 2
1 2
1
1 2
0 1
1  1
m
k k I tm
k k I
H
k
H
H k k I
e
H k
 
 
          
Whereas the additional condition of absence of inhibitor (I=0) produces:
1
0
1 1
m
k tm
H
H
H
e
H


   
 
That is to say, the logistic equation as a description of an autocatalytic process.
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Figure 1: Relationships between DR curves for the two effectors as against the same 
receptor or one effector as against two different receptors (equivalent to the assessment 
of one effector by two different methods). The represented case is the most general, 
where the maximum response, the slope and the correspondent dose to the semi 
maximum response vary. Take notice that to calculate the D1 dose which produces in 
R1 an equivalent response to the D2 dose in R2, it must be taking into account that: 1) in 
the domains of the highlighted surfaces the relative magnitudes of the responses are 
reversed; 2) the conversion function  is only applied in the abscissa interval between 
the domains A and B. That is, from the end of the starting to the beginning of the 
asymptotic stretch of the reference curve (herein R2).
Figure1
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Figure 2: Palytoxin hemolytic kinetics at  37ºC. For further details, see text.
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Figure 3: Surface of dose-time response (S2 criteria) belonging to the palytoxin 
hemolysis at 37ºC. For further details, see text.
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Figure 4: Palytoxin hemolysis kinetic at different temperatures. Fit of the experimental 
results (dots) according to the logistic models (continuous lines). For the estimation of 
the speed parameters , see text. 
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Figure 5: On the top, temperature effect over the kinetics parameters (on the left: m, on 
the right: vm) of the palytoxin hemolysis. On the bottom , fit of the Arrhenius equation 
of the kinetic parameters belonging to the increasing speed stench, for the calculus of 
the activation energy. 
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Figure 6: Catalytic hypothesis (on the top) in contrast to populational hypothesis, 
according to the models mL (in the middle) and mW (on the bottom), in the Ouabain 
inhibition of the palytoxin hemolysis. Absence ()and presence of 5 (), 4 (), 3 () 
and 2 () M of ouabain.
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Figure 7: Dose-time response surfaces (S2 criteria) for the palytoxin hemolysis at 25ºC, 
absence (on the top) and presence of 1 M (in the middle) and 5 M of Ouabain (on the 
bottom). For further details, see text.
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Figure 8: DR curves of asymptotic response times. On the top: at 37ºC; on the bottom: 
at 25 ºC in  absence () and presence of 1 () and 2 () M of ouabain.
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Figure 9: Fitting of the palytoxin responses to the models  mL (continuous lines) and mW 
(dotted lines) according to the hemolytic assays (PHO: at 25ºC with 5 M of Ouabain  
(on the left)) and to the mouse bioassay (on the right).
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TABLE 1: Basic parameters of the hemolysis by palytoxin, under the specified conditions, 
as estimated by means of the criteria discussed in the text. t0.5 and m: time and dose for 
semi-maximum response, in minutes and pg.ml–1, respectively; OU: ouabain. In equation 
[8], we give maximum and minimum t0.5 obtained when adjusting separately the kinetic 
series; in the rest of the cases, the confidence intervals for =0.05 are specified.
Evaluation criteria
conditions eq. [8] S1 a S2
37ºC t0.5 173-233 - 185  2
m - 14.5  3.0 b 25.3  3.9
25ºC t0.5 222-399 - 245  8
m - 10.3  1.8 27.6  5.0
25ºC; OU 1 M t0.5 272-450 - 303  7
m - 94.1  6.8 132.3  9.4
25ºC; OU 5 M t0.5 375-454 - 395  7
m - 260.2  11.4 277.0  7.3
(a) At asymptotic response time.
(b) 29.2  7.0 if the results at 250, 300 and 350 minutes are jointly considered (as 
in figure 3D).
Table 1
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TABLE 2: Parametric estimates of the hemolysis rate at different temperatures, 
as obtained by fitting of the experimental results to the equations [10] and [11]. 
Confidence intervals (=0.05) and correlation coefficients (r) between 
observations and predictions are specified ([10] and [11] are parametric forms of 
the same equation and, consequently, the corresponding r are coincident).
T (ºC - K) m [eq. 10] vm [eq. 11] r
15 - 288 0.664  0.169 15.772  3.783 0.999
20 - 293 0.793  0.255 17.796  5.411 0.996
25 - 298 0.942  0.169 19.188  3.286 0.997
30 - 303 0.973  0.176 20.533  3.517 0.997
35 - 308 1.136  0.313 22.589  6.007 0.994
40 - 313 0.996  0.297 18.181  5.090 0.981
45 - 318 0.490  0.141 11.057  2.412 0.982
Table 2
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TABLE 3: Parameters of the DR relationships concerning palytoxin, according to the 
mouse bioassay, and hemolysis assay at 25ºC in the presence of ouabain, calculated 
through the fitting of the experimental results to the models mL and mW. See also figure 
10.
mouse bioassay hemolysis assay (PHO)
K 1.008  0.040 0.987  0.023
 2.258  0.687 6.989  0.862
m 5.870  0.146 0.263  0.009eq. 
mL [4] 
r 0.996 0.999
K 1.003  0.029 0.990  0.026
a 9.340  1.943  1.508  0.126
m 5.892  0.108 0.260  0.011eq. 
mW [6] 
r 0.998 0.999
Table 3
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Table of symbolic notations used.
H : Normalized hemolysis. Dimensions: percent (or unitary fraction) of hemolysis.
t : Time.
Hm : Maximum hemolysis. Dimensions: percent (or unitary fraction) of hemolysis.
m : Maximum specific rate of hemolysis. Dimensions: t–1
H0 : Initial hemolysis. Dimensions: %H
vm : Maximum growth rate of hemolysis. Dimensions: %H.t
–1
: Hemolysis lag phase. Dimensions: t
kr: Kinetic constant. Dimensions: Arbitraries (for example, 1
st order kinetic: t–1)
T : Absolute temperature. Dimensions: Kelvin (K)
A: Arrhenius pre-exponential factor. Dimensions: Arbitrary (e.g. 1st order kinetic: t–1)
Ea (kr): Activation energy (kr). Dimensions: J.mol
-1
A1: Arrhenius pre-exponential factor (m). Dimensions: t–1
A2: Arrhenius pre-exponential factor (vm). Dimensions: %H.t
–1
R: Gas-law constant. Value and dimensions: 8.315 J.mol-1.K-1
Ea (m): Activation energy (m). Dimensions: J.mol-1
Ea (vm): Activation energy (vm). Dimensions: J.mol
-1
Table4
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